Microbot Medical INC Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
NASDAQ
Rachel Vaknin, CFO of Microbot Medical Inc., reports the acquisition of stock options and the vesting of performance-based options.
NASDAQ
Harel Gadot, CEO of Microbot Medical Inc., reports the acquisition of stock options and the vesting of performance-based options.
NASDAQ
Sharon Simon, General Manager and CTO of Microbot Medical Inc., reports the acquisition of stock options.
NASDAQ
Juan Diaz-Cartelle, Chief Medical Officer of Microbot Medical Inc., reports the acquisition of stock options and the vesting of performance-based options.
NASDAQ
Martin J. Madden, a director of Microbot Medical Inc., reports the acquisition of stock options.
NASDAQ
Scott R. Burell, a director of Microbot Medical Inc., acquired stock options exercisable for 10,000 shares on January 28, 2025.
NASDAQ
Tal Baruch Wenderow, a director of Microbot Medical Inc., acquired 10,000 stock options on January 28, 2025.
NASDAQ
David James Wilson, a director of Microbot Medical Inc., acquired 20,000 stock options on January 28, 2025, exercisable at $1.93.
NASDAQ
Director Aileen Stockburger acquired 10,000 stock options in Microbot Medical Inc. on January 28, 2025.
NASDAQ
Director Prattipati Laxminarain reports acquisition of 10,000 Microbot Medical Inc. stock options.